Overall, our pan-cancer analyses of GPX8 have clarified the landscape of GPX8 expression with the clinical prognosis and immune cell infiltration, which provided a predictive biomarker in pan-cancer, especially in the GBM/LGG, KIRC, KIRP and STAD. The gene discussed is GPX8; the disease is cancer.